Identification Generic Name (2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid DrugBank Accession Number DB04742 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid (DB04742) ×  Close Weight Average: 326.391  Monoisotopic: 326.039498326  Chemical Formula C 13 H 14 N 2 O 4 S 2 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U D-alanyl-D-alanine carboxypeptidase Not Available Actinomadura sp. (strain R39) Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 1,3-thiazines. These are organic compounds containing 1,3-thiazine, a six-member ring with a nitrogen and a sulfur atoms in ring positions 1 and 3 respectively, as well as two double bonds. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Thiazines Sub Class 1,3-thiazines Direct Parent 1,3-thiazines Alternative Parents Thiophenes  /  Heteroaromatic compounds  /  Secondary carboxylic acid amides  /  Ketimines  /  Propargyl-type 1,3-dipolar organic compounds  /  Monocarboxylic acids and derivatives  /  Dialkylthioethers  /  Carboxylic acids  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Aldehydes 
 
 
  show 3 more Substituents Aldehyde  /  Aromatic heteromonocyclic compound  /  Azacycle  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid  /  Carboxylic acid derivative  /  Dialkylthioether  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Imine  /  Ketimine  /  Meta-thiazine  /  Monocarboxylic acid or derivatives  /  Organic 1,3-dipolar compound  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Propargyl-type 1,3-dipolar organic compound  /  Secondary carboxylic acid amide  /  Thioether  /  Thiophene 
 
 
  show 15 more Molecular Framework Aromatic heteromonocyclic compounds External Descriptors thiazinemonocarboxylic acid ( CHEBI:44267 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key QIZKCGBBVPUBJL-ZYHUDNBSSA-N InChI InChI=1S/C13H14N2O4S2/c16-7-10(12-15-9(13(18)19)3-5-21-12)14-11(17)6-8-2-1-4-20-8/h1-2,4,7,10,12H,3,5-6H2,(H,14,17)(H,18,19)/t10-,12-/m1/s1 IUPAC Name (2R)-2-[(1R)-2-oxo-1-[2-(thiophen-2-yl)acetamido]ethyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid SMILES [H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@@]1([H])SCCC(=N1)C(O)=O References General References Not Available External Links PubChem Compound 5288990 PubChem Substance 46505603 ChemSpider 4451047 ZINC ZINC000012504489 PDBe Ligand NCF PDB Entries 1w8y Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0551 mg/mL ALOGPS logP 0.93 ALOGPS logP 1.43 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 3.57 Chemaxon pKa (Strongest Basic) -1.5 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 95.83 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 78.94 m 3 ·mol -1 Chemaxon Polarizability 30.73 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption - 0.9358 Blood Brain Barrier - 0.6466 Caco-2 permeable - 0.7235 P-glycoprotein substrate Substrate 0.5 P-glycoprotein inhibitor I Non-inhibitor 0.9593 P-glycoprotein inhibitor II Non-inhibitor 0.9912 Renal organic cation transporter Non-inhibitor 0.81 CYP450 2C9 substrate Non-substrate 0.7996 CYP450 2D6 substrate Non-substrate 0.8192 CYP450 3A4 substrate Non-substrate 0.6767 CYP450 1A2 substrate Non-inhibitor 0.8259 CYP450 2C9 inhibitor Non-inhibitor 0.9007 CYP450 2D6 inhibitor Non-inhibitor 0.911 CYP450 2C19 inhibitor Non-inhibitor 0.9152 CYP450 3A4 inhibitor Non-inhibitor 0.9103 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9561 Ames test Non AMES toxic 0.8375 Carcinogenicity Non-carcinogens 0.9457 Biodegradation Not ready biodegradable 0.8685 Rat acute toxicity 2.1491 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9954 hERG inhibition (predictor II) Non-inhibitor 0.9364    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  D-alanyl-D-alanine carboxypeptidase Kind Protein Organism Actinomadura sp. (strain R39) Pharmacological action Unknown General Function Serine-type d-ala-d-ala carboxypeptidase activity Specific Function Removes C-terminal D-alanyl residues from sugar-peptide cell wall precursors. Gene Name dac Uniprot ID P39045 Uniprot Name D-alanyl-D-alanine carboxypeptidase Molecular Weight 54973.425 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52 